| Risk Factor . | Total Population, % . | White, % . | AA, % . | P value . |
|---|---|---|---|---|
| Elevated fasting blood glucose or treatment, ≥ 100 mg/dL | 160 (16.8) | 66 (13.1) | 94 (21.2) | .001 |
| Reduced HDL-C or treatment (women < 50 mg/dL, men < 40 mg/dL) | 220 (23.1) | 119 (23.8) | 101 (23.1) | .817 |
| Elevated triglycerides or treatment, ≥ 150 mg/dL | 192 (20.1) | 119 (23.8) | 73 (16.7) | .007 |
| Elevated BP or treatment, BP ≥ 130/85 mm Hg | 355 (37.3) | 148 (29.4) | 207 (46.5) | <.001 |
| Elevated waist circumference (women ≥ 80 cm, men ≥ 94 cm) or BMI (≥30 kg/m2) | 568 (59.9) | 268 (53.2) | 300 (67.4) | <.001 |
| Risk Factor . | Total Population, % . | White, % . | AA, % . | P value . |
|---|---|---|---|---|
| Elevated fasting blood glucose or treatment, ≥ 100 mg/dL | 160 (16.8) | 66 (13.1) | 94 (21.2) | .001 |
| Reduced HDL-C or treatment (women < 50 mg/dL, men < 40 mg/dL) | 220 (23.1) | 119 (23.8) | 101 (23.1) | .817 |
| Elevated triglycerides or treatment, ≥ 150 mg/dL | 192 (20.1) | 119 (23.8) | 73 (16.7) | .007 |
| Elevated BP or treatment, BP ≥ 130/85 mm Hg | 355 (37.3) | 148 (29.4) | 207 (46.5) | <.001 |
| Elevated waist circumference (women ≥ 80 cm, men ≥ 94 cm) or BMI (≥30 kg/m2) | 568 (59.9) | 268 (53.2) | 300 (67.4) | <.001 |
BMI was reported in patients with missing waist circumference values. Bold values indicate statistically significant difference (P < .05).
| Risk Factor . | Total Population, % . | White, % . | AA, % . | P value . |
|---|---|---|---|---|
| Elevated fasting blood glucose or treatment, ≥ 100 mg/dL | 160 (16.8) | 66 (13.1) | 94 (21.2) | .001 |
| Reduced HDL-C or treatment (women < 50 mg/dL, men < 40 mg/dL) | 220 (23.1) | 119 (23.8) | 101 (23.1) | .817 |
| Elevated triglycerides or treatment, ≥ 150 mg/dL | 192 (20.1) | 119 (23.8) | 73 (16.7) | .007 |
| Elevated BP or treatment, BP ≥ 130/85 mm Hg | 355 (37.3) | 148 (29.4) | 207 (46.5) | <.001 |
| Elevated waist circumference (women ≥ 80 cm, men ≥ 94 cm) or BMI (≥30 kg/m2) | 568 (59.9) | 268 (53.2) | 300 (67.4) | <.001 |
| Risk Factor . | Total Population, % . | White, % . | AA, % . | P value . |
|---|---|---|---|---|
| Elevated fasting blood glucose or treatment, ≥ 100 mg/dL | 160 (16.8) | 66 (13.1) | 94 (21.2) | .001 |
| Reduced HDL-C or treatment (women < 50 mg/dL, men < 40 mg/dL) | 220 (23.1) | 119 (23.8) | 101 (23.1) | .817 |
| Elevated triglycerides or treatment, ≥ 150 mg/dL | 192 (20.1) | 119 (23.8) | 73 (16.7) | .007 |
| Elevated BP or treatment, BP ≥ 130/85 mm Hg | 355 (37.3) | 148 (29.4) | 207 (46.5) | <.001 |
| Elevated waist circumference (women ≥ 80 cm, men ≥ 94 cm) or BMI (≥30 kg/m2) | 568 (59.9) | 268 (53.2) | 300 (67.4) | <.001 |
BMI was reported in patients with missing waist circumference values. Bold values indicate statistically significant difference (P < .05).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
